Therapy News and Research

RSS

New method uses biomarkers to determine a person's biological age

Aging is a highly individual process. An international consortium coordinated by researchers in Konstanz has developed a method that uses biomarkers to determine a person's biological age - a valuable tool for research on ageing and the development of new approaches in preventive medicine.

19 Mar 2026

Expanded access to rotational atherectomy maintains safety in PCI procedures

Percutaneous coronary intervention (PCI) is a standard treatment for significant coronary artery disease. Cardiologists use a catheter to place a stent that opens up the blockage and restores blood flow to the heart.

19 Mar 2026

How long should you take GLP-1 drugs? Study links longer use to lower heart risk

Continuous use of GLP-1 receptor agonists in adults with type 2 diabetes was associated with a lower risk of major cardiovascular events compared with sulfonylureas, with benefits increasing over time. Discontinuation or interruption was associated with a progressive loss of this protective effect, with risks approaching those of comparator therapy.

19 Mar 2026

New compound targets the neuronal epigenome to treat Alzheimer's disease

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease.

19 Mar 2026

Tumor debulking fails to improve survival in colorectal cancer

Research shows tumor debulking in advanced colorectal cancer does not enhance survival outcomes and may increase adverse effects, questioning its efficacy.

19 Mar 2026

Menopause may raise women’s Alzheimer risk earlier than doctors once thought

This review argues that women’s higher Alzheimer disease risk may be shaped in part by midlife neuroendocrine aging, especially the menopause transition, rather than by longevity alone. It highlights early menopause, bilateral oophorectomy, vasomotor symptoms, and midlife cognitive changes as underinvestigated but potentially important risk markers, while calling for sex-specific, biomarker-driven prevention strategies.

18 Mar 2026

Blocking a single protein could make hidden HPV-positive tumors vulnerable to treatment

A team of scientists at Henry Ford Health + Michigan State University Health Sciences have uncovered a mechanism that allows certain head and neck cancers to hide from the immune system, a discovery that could change how some of the most treatment resistant tumors are approached.

18 Mar 2026

New mechanism drives adverse tumor remodeling during breast cancer progression

A research group led by Professor Cecilia Sahlgren at Åbo Akademi University (Finland) and the InFLAMES Research Flagship has identified a new mechanism directing the adverse remodeling of tumor tissue during breast cancer progression.

18 Mar 2026

Stopping GLP-1 treatment linked to increase in risk of major cardiovascular events

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits.

18 Mar 2026

Muscle-repairing macrophages trigger heterotopic ossification in mice

We have identified a macrophage population "Mrep" that plays an essential role in muscle repair. However, in Fibrodysplasia ossificans progressiva (FOP), Mrep functions as a pathogenic cell that triggers heterotopic ossification.

18 Mar 2026

Burnout crisis demands science-based strategies beyond self-care solutions

Burnout is at an all-time high, with some studies saying two-thirds of employees now cite job burnout as a major challenge.

18 Mar 2026

Combination therapy shows promise for leptomeningeal metastasis in breast cancer

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted therapies, tucatinib and trastuzumab, plus the chemotherapy drug, capecitabine, may improve symptoms and extend survival in some breast cancer patients with LM.

18 Mar 2026

Aptamer Group launches targeted radiopharmaceutical program

Aptamer Group plc, the developer of next‑generation synthetic binders for the life sciences industry, today announced the launch of a new targeted radiopharmaceutical program in collaboration with Radiopharmium Ltd, a UK-based specialist consultancy in radiopharmaceutical development.

From Aptamer Group 18 Mar 2026

New nanoparticle therapy overcomes T cell exhaustion in solid tumors

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including common variants such as cancers of the breast, liver and colon.

18 Mar 2026

New approach developed to visualize proteins at unprecedented scale and sensitivity

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest questions.

18 Mar 2026

Maker of device to treat addiction withdrawal seeks counties’ opioid settlement cash

In the early 2000s, Michelle Warfield worked at a factory, hauling heavy seats for Ford trucks on and off an assembly line. To suppress daily aches in her back and hips, her doctor prescribed opioid painkillers.

18 Mar 2026

New microbiome therapy improves autism symptoms in children

This study evaluates a new fecal microbiota transplant method, revealing significant symptom improvements in children with autism without invasive procedures.

18 Mar 2026

Sartorius launches next-generation platform to boost efficiency in cell therapy production

The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.

From Sartorius 18 Mar 2026

Scaffold-free muscle patches show promise for injury repair

Traumatic muscle injury can be associated with volumetric muscle loss (VML), often leading to permanent functional loss.

17 Mar 2026

Breakfast, exercise, and sleep linked to better mental resilience

Do you ever feel mentally stuck, like you can't cope when a stressful situation hits? A healthy breakfast, exercise, and a good night's sleep might be just what you need to build psychological flexibility, and new research from Binghamton University shows why that matters.

17 Mar 2026

Previous
1
...
61
62
63
64
65
66
67
...
2932
Next

Therapy News and Research

New method uses biomarkers to determine a person's biological age

Expanded access to rotational atherectomy maintains safety in PCI procedures

How long should you take GLP-1 drugs? Study links longer use to lower heart risk

New compound targets the neuronal epigenome to treat Alzheimer's disease

Tumor debulking fails to improve survival in colorectal cancer

Menopause may raise women’s Alzheimer risk earlier than doctors once thought

Blocking a single protein could make hidden HPV-positive tumors vulnerable to treatment

New mechanism drives adverse tumor remodeling during breast cancer progression

Stopping GLP-1 treatment linked to increase in risk of major cardiovascular events

Muscle-repairing macrophages trigger heterotopic ossification in mice

Burnout crisis demands science-based strategies beyond self-care solutions

Combination therapy shows promise for leptomeningeal metastasis in breast cancer

Aptamer Group launches targeted radiopharmaceutical program

New nanoparticle therapy overcomes T cell exhaustion in solid tumors

New approach developed to visualize proteins at unprecedented scale and sensitivity

Maker of device to treat addiction withdrawal seeks counties’ opioid settlement cash

New microbiome therapy improves autism symptoms in children

Sartorius launches next-generation platform to boost efficiency in cell therapy production

Scaffold-free muscle patches show promise for injury repair

Breakfast, exercise, and sleep linked to better mental resilience

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News